Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
BIIB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Financial results
Filed 8-K for an event or period dated 2026-10-28. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: third_quarter 2026 lobbying report
Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process
Public: Oct 20, 2026, 11:09 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: third_quarter 2026 lobbying report
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements. Issues related to the 340B program. Issues related to rare disease and treatment. Drug pricing policy. Public policy around patien
Public: Oct 20, 2026, 1:02 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: third_quarter 2026 lobbying report
Issues related to Alzheimer's disease and dementia, including screening, diagnosis, and care. Issues related to postpartum depression screening, detection, and education. Issues related to ALS, lupus, and kidney disease policy. IRA implementation. Issues related to drug pricing. 340B Program. Supply Chain. Issues related to patient affordability and access including copay and coverage reform. Issues related to PBM reform. PDUFA, drug reviews, approval pathways, PPRV Program, clinical trials. Issues related to rare diseases, including the Orphan Drug and ORPHAN CURES Act, rare disease research
Public: Oct 19, 2026, 11:37 AM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Sep 17, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Financial results
Filed 8-K for an event or period dated 2026-07-29. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment
The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peripheral and Central Nervous System Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Peripheral and Central Nervous System Drugs Advisory Committee was terminated on June 4, 2026, because its charter was not renewed on or before that expiration date. The Commissioner has determined that it is in the public interest to reestablish the Peripheral and Central Nervous System Drugs Advisory Committee for 2 years from the date it is reestablished.
Public: Jul 23, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: second_quarter 2026 lobbying report
Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process
Public: Jul 20, 2026, 10:30 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: second_quarter 2026 lobbying report
Alzheimer's Disease. Medicare Reimbursement for Prescription Drugs. Screening and Diagnosis, PET scan coverage and reimbursement and dementia care. 340B Program. PPRV (Pediatric Priority Review Voucher) program. Drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements. Implementation of Inflation Reduction Act of 2022. Issues related to maternal health. 340B Program.
Public: Jul 20, 2026, 7:28 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: second_quarter 2026 lobbying report
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. Intellectual property protections and enforcement. Biopharmaceutical patent policy. Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathwa
Public: Jul 20, 2026, 5:22 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Financial results
Filed 8-K for an event or period dated 2026-07-01. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: 8-K company filing
Filed 8-K for an event or period dated 2026-06-09. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: 8-K/A company filing
Filed 8-K/A for an event or period dated 2026-05-14. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
BIIB: Material agreement · Acquisition or asset disposal · New financial obligation · Company disclosure
Filed 8-K for an event or period dated 2026-05-14. Material agreement; Acquisition or asset disposal; New financial obligation; Company disclosure.
1 congressional household disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 7:56 AM EST
- USAspending
- Collection in progress129 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 7:47 AM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 6:27 AM EST
- Federal Register
- Collection in progress298 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 7:47 AM EST
- Regulations.gov
- Partial coverage — some requests unavailable27 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 7:47 AM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST